期刊文献+

慢病毒载体介导RNA干扰质粒转染小鼠血管瘤内皮细胞的条件优化 被引量:1

Optimization of transfection conditions for transfecting shRNA to endothelium of mouse angioma cells mediated by lentiviral vector.
原文传递
导出
摘要 目的优化在慢病毒介导下将含有针对小鼠α1,3GT的RNA干扰质粒导入小鼠血管瘤内皮细胞(EOMA)时的转染条件。方法按是否加入促转染剂Polybrene(8μ/ml),感染复数(MOI)分别为1、5、10、15和20,感染时间分别为4、6、12和24h,将EOMA细胞分为40个组,分别加入相应的慢病毒转染混合液,于转染后140h在荧光显微镜下计数阳性细胞率,台盼蓝染色法检测各转染条件下的EOMA细胞活性。结果不同病毒感染复数、不同感染时间及有、无促转染剂Polybrene的各组间病毒对EOMA细胞的转染效率差异有统计学意义,其中当加入Polybrene(8μg/ml),MOI=5,感染时间为6h时,转染效率达到最高(83%),细胞活性良好,存活率为96%,此后再增加MOI值和感染时间,转染效率未继续增加,而对细胞的毒性作用明显增强。结论加入Polybrene(8μg/ml),MOI=5,感染时间为6h时可以实现慢病毒载体对EO-MA细胞的高效转染并保持较高的细胞活性。 Objective To optimize the transfection parameters for transfecting small interfering RNA (siRNA) to endothelium of mouse angioma (EOMA) cells mediated by lentiviral vector. Methods According to Polybrene existing or not (8 μg/ml), series of multiplicity of infection (MOI) ( 1,5, 10, 15, 20)and the time of infection (4, 6, 12,24 h), EOMA cells were divided into 40 groups. 140 hours after transfection, cells were counted under fluorescent microscope to determine the percentage of the cells transfected under each condition. The cell viability was calculated by using Typan Blue. Results The percentage of positive cells was as high as 83% in the group with Polybrene (8 μg/ml), MOI(5) and the time of tranfection ( 6 h), and the livability of EOMA in this group was 96%. After that, the transfection efficiency was not increased with the increasing of MOI, the time of transfection, but the mortality of EOMA was increased markedly. Conclusion The transfection efficiency and cell viability are dependent on the Polybrene(8 μg/ml) , correct MOI (5)and the time of transfection(6 h).
出处 《中国综合临床》 2009年第6期565-567,共3页 Clinical Medicine of China
基金 国家自然科学基金资助项目(30500489)
关键词 慢病毒载体 RNA干扰 转染 血管内皮细胞 Lentiviral vector RNA interference Transfection Endothelial cell
  • 相关文献

参考文献9

  • 1Wu GY,Wu CH.Delivery systems for gene therapy[J].Biotherapy,1991,3(1):87-95.
  • 2Pari GS,Keown WA.Experimental strategies in efficient transfection of mammalian cells.Calcium phosphate and DEAE-dextran[J].Methods Mol Biol,1997,62:301-306.
  • 3Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391 (6669):806-811.
  • 4]Chiu YL,Rana TM.RNAi in human cells:basic structural and functional features of small interfering RNA[J].Mol Cell,2002,10 (3):549-561.
  • 5Bmmmelkamp TR,Bemards R,Agami R.Stable suppression of tumorigenicity by virus-modiatod RNA interference[J].Cancer Cell,2002,2(3):243-247.
  • 6Zender L,Hutker S,Liedtke C,et al.Caspase 8 small interfering RNA prevents acute liver failure in mice[J].Prec Nell Acad Sci USA,2003,100(13):7797-7802.
  • 7Jacque JM,Triques K,Stevenson M.Modulation of HIV-1 replication by RNA interference[J].Nature,2002,418(6896):435-438.
  • 8白垚,郭建新,陈辉,郑秀惠,颜耀华.慢病毒介导人乳头瘤病毒16型E6基因短发夹状干扰RNA对宫颈癌细胞感染效率和侵袭能力的影响[J].中国综合临床,2008,24(5):440-442. 被引量:3
  • 9Bartosch B,Cosset FL.Strategies for retargeted gene delivery using vectors derived from lentiviruses[J].Curt Gene Ther,2004,4(4):427-443.

二级参考文献12

  • 1郭建新,李力,白垚,程小星,邓少丽,郑秀惠.慢病毒携带shRNA对宫颈癌细胞中HPV16型E6表达的抑制作用[J].第三军医大学学报,2006,28(11):1218-1220. 被引量:5
  • 2Anderson SM. Human papillomavirus and cervical cancer[ J]. Clinical Microbiology Newsletter ,2002,24 ( 15 ) : 113-118.
  • 3Defilippis RA, Goodwin EC, Wu LL, et al. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells[ J]. Virol, 2003,77(2) :1551-1563.
  • 4Brantl S. Antisense-RNA regulation and RNA interference[ J]. Biochim Biophys Acta,2002,1575 ( 1-3 ) : 15-25.
  • 5Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs [ J]. Methods, 2002,26 ( 2 ) : 199 -213.
  • 6Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siR3/A, a primer of RNA interference [ J ]. Oncogene, 2002,21 ( 39 ) : 6041- 6048.
  • 7Yoshinouchi M, Yamada T, Kizaki M, et al. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA [ J ]. Mol Ther,2003,8 (5) :762-768.
  • 8Rubinson D, Dillon C, Kwiatkowski A, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interfering[J]. Nature Genet, 2003,33 ( 3 ) :401-406.
  • 9Butz K, Ristriani T, Hengstermann A, et al. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells [ J ]. Oncogene ,2003,22 ( 38 ) :5938-5945.
  • 10Bartosch B, Cosset FL. Strategies for retargeted gene delivery using vectors derived from lentiviruses [ J ]. Curr Gene Ther,2004,4 (4) : 427-443.

共引文献2

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部